Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Development and Validation of a Pragmatic Electronic Phenotype for CKD.

Norton JM, Ali K, Jurkovitz CT, Kiryluk K, Park M, Kawamoto K, Shang N, Navaneethan SD, Narva AS, Drawz P.

Clin J Am Soc Nephrol. 2019 Aug 12. pii: CJN.00360119. doi: 10.2215/CJN.00360119. [Epub ahead of print]

PMID:
31405830
2.

Patient Satisfaction with Care After Coronary Revascularization.

Mosby DL, Manierre MJ, Martin SS, Kolm P, Abuzaid AS, Jurkovitz CT, Elliott DJ, Weintraub WS.

Patient. 2018 Apr;11(2):217-223. doi: 10.1007/s40271-017-0274-4.

PMID:
28875457
3.

Dietary sodium and health: more than just blood pressure.

Farquhar WB, Edwards DG, Jurkovitz CT, Weintraub WS.

J Am Coll Cardiol. 2015 Mar 17;65(10):1042-50. doi: 10.1016/j.jacc.2014.12.039. Review.

4.

Risk factors for cardiovascular events and bleeding complications following non-cardiac surgery or procedure in patients with drug eluting stent placement.

Tiwari D, Jurkovitz CT, Zhang Z, Bowen J, Kolm P, Wygant G, Weintraub WS.

Heart Asia. 2014 May 22;6(1):69-75. doi: 10.1136/heartasia-2013-010471. eCollection 2014.

5.

Health status and quality of life in patients with stable coronary artery disease and chronic kidney disease treated with optimal medical therapy or percutaneous coronary intervention (post hoc findings from the COURAGE trial).

Sedlis SP, Jurkovitz CT, Hartigan PM, Kolm P, Goldfarb DS, Lorin JD, Dada M, Maron DJ, Spertus JA, Mancini GB, Teo KK, Boden WE, Weintraub WS; COURAGE Study Investigators.

Am J Cardiol. 2013 Dec 1;112(11):1703-8. doi: 10.1016/j.amjcard.2013.07.034. Epub 2013 Sep 3.

6.

Association between lack of health insurance and risk of death and ESRD: results from the Kidney Early Evaluation Program (KEEP).

Jurkovitz CT, Li S, Norris KC, Saab G, Bomback AS, Whaley-Connell AT, McCullough PA; KEEP Investigators.

Am J Kidney Dis. 2013 Apr;61(4 Suppl 2):S24-32. doi: 10.1053/j.ajkd.2012.12.015.

7.

Advances in CKD detection and determination of prognosis: executive summary of the National Kidney Foundation-Kidney Early Evaluation Program (KEEP) 2012 annual data report.

Whaley-Connell AT, Kurella Tamura M, Jurkovitz CT, Kosiborod M, McCullough PA.

Am J Kidney Dis. 2013 Apr;61(4 Suppl 2):S1-3. doi: 10.1053/j.ajkd.2013.01.006. No abstract available.

8.

Association of physician care with mortality in Kidney Early Evaluation Program (KEEP) participants.

Saab G, Chen SC, Li S, Bomback AS, Whaley-Connell AT, Jurkovitz CT, Norris KC, McCullough PA; KEEP Investigators.

Am J Kidney Dis. 2012 Mar;59(3 Suppl 2):S34-9. doi: 10.1053/j.ajkd.2011.11.020.

9.

Physician utilization, risk-factor control, and CKD progression among participants in the Kidney Early Evaluation Program (KEEP).

Jurkovitz CT, Elliott D, Li S, Saab G, Bomback AS, Norris KC, Chen SC, McCullough PA, Whaley-Connell AT; KEEP Investigators.

Am J Kidney Dis. 2012 Mar;59(3 Suppl 2):S24-33. doi: 10.1053/j.ajkd.2011.11.019.

10.

Racial and ethnic differences in mortality among individuals with chronic kidney disease: results from the Kidney Early Evaluation Program (KEEP).

Jolly SE, Burrows NR, Chen SC, Li S, Jurkovitz CT, Norris KC, Shlipak MG.

Clin J Am Soc Nephrol. 2011 Aug;6(8):1858-65. doi: 10.2215/CJN.00500111. Epub 2011 Jul 22.

11.

Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP).

Stevens LA, Li S, Wang C, Huang C, Becker BN, Bomback AS, Brown WW, Burrows NR, Jurkovitz CT, McFarlane SI, Norris KC, Shlipak M, Whaley-Connell AT, Chen SC, Bakris GL, McCullough PA.

Am J Kidney Dis. 2010 Mar;55(3 Suppl 2):S23-33. doi: 10.1053/j.ajkd.2009.09.035.

12.

Racial and ethnic differences in albuminuria in individuals with estimated GFR greater than 60 mL/min/1.73 m(2): results from the Kidney Early Evaluation Program (KEEP).

Jolly SE, Burrows NR, Chen SC, Li S, Jurkovitz CT, Narva AS, Norris KC, Shlipak MG.

Am J Kidney Dis. 2010 Mar;55(3 Suppl 2):S15-22. doi: 10.1053/j.ajkd.2009.09.034.

13.

Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease.

Sedlis SP, Jurkovitz CT, Hartigan PM, Goldfarb DS, Lorin JD, Dada M, Maron DJ, Spertus JA, Mancini GB, Teo KK, O'Rourke RA, Boden WE, Weintraub WS; COURAGE Study Investigators.

Am J Cardiol. 2009 Dec 15;104(12):1647-53. doi: 10.1016/j.amjcard.2009.07.043.

PMID:
19962469
14.

Risk factors for chronic kidney disease among American Indians and Alaska Natives--findings from the Kidney Early Evaluation Program.

Jolly SE, Li S, Chen SC, Narva AS, Jurkovitz CT, Norris KC, Shlipak MG.

Am J Nephrol. 2009;29(5):440-6. doi: 10.1159/000174857. Epub 2008 Nov 14.

15.

Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality.

McCullough PA, Li S, Jurkovitz CT, Stevens L, Collins AJ, Chen SC, Norris KC, McFarlane S, Johnson B, Shlipak MG, Obialo CI, Brown WW, Vassalotti J, Whaley-Connell AT, Brenner RM, Bakris GL; KEEP Investigators.

Am Heart J. 2008 Aug;156(2):277-83. doi: 10.1016/j.ahj.2008.02.024. Epub 2008 Jun 4. Erratum in: Am Heart J. 2008 Dec;156(6):1132. Vassaloti, Joseph [corrected to Vassalotti, Joseph].

PMID:
18657657
16.

CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.

McCullough PA, Li S, Jurkovitz CT, Stevens LA, Wang C, Collins AJ, Chen SC, Norris KC, McFarlane SI, Johnson B, Shlipak MG, Obialo CI, Brown WW, Vassalotti JA, Whaley-Connell AT; Kidney Early Evaluation Program Investigators.

Am J Kidney Dis. 2008 Apr;51(4 Suppl 2):S38-45. doi: 10.1053/j.ajkd.2007.12.017.

PMID:
18359407
17.

The Kidney Early Evaluation Program (KEEP): program design and demographic characteristics of the population.

Jurkovitz CT, Qiu Y, Wang C, Gilbertson DT, Brown WW.

Am J Kidney Dis. 2008 Apr;51(4 Suppl 2):S3-12. doi: 10.1053/j.ajkd.2007.12.022.

PMID:
18359405
18.

Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP).

McCullough PA, Jurkovitz CT, Pergola PE, McGill JB, Brown WW, Collins AJ, Chen SC, Li S, Singh A, Norris KC, Klag MJ, Bakris GL; KEEP Investigators.

Arch Intern Med. 2007 Jun 11;167(11):1122-9.

PMID:
17563019
19.

Comparison of recovery after mitral valve repair and replacement.

Zhao L, Kolm P, Borger MA, Zhang Z, Lewis C, Anderson G, Jurkovitz CT, Borkon AM, Lyles RH, Weintraub WS.

J Thorac Cardiovasc Surg. 2007 May;133(5):1257-63.

20.

Reduced 6-month resource use and costs associated with cilostazol in patients after successful coronary stent implantation: results from the Cilostazol for RESTenosis (CREST) trial.

Zhang Z, Foster JK, Kolm P, Jurkovitz CT, Parker KM, Murrah NV, Anderson GT, Douglas JS Jr, Weintraub WS.

Am Heart J. 2006 Oct;152(4):770-6.

PMID:
16996857
21.

Obesity is associated with family history of ESRD in incident dialysis patients.

Speckman RA, McClellan WM, Volkova NV, Jurkovitz CT, Satko SG, Schoolwerth AC, Freedman BI.

Am J Kidney Dis. 2006 Jul;48(1):50-8.

PMID:
16797386
22.
23.

Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study.

Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS, McClellan W.

Kidney Int. 2003 Aug;64(2):610-5.

24.

Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction.

Mahoney EM, Jurkovitz CT, Chu H, Becker ER, Culler S, Kosinski AS, Robertson DH, Alexander C, Nag S, Cook JR, Demopoulos LA, DiBattiste PM, Cannon CP, Weintraub WS; TACTICS-TIMI 18 Investigators. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction.

JAMA. 2002 Oct 16;288(15):1851-8.

PMID:
12377083
25.

Intravascular radiation therapy after balloon angioplasty of narrowed femoropopliteal arteries to prevent restenosis: results of the PARIS feasibility clinical trial.

Waksman R, Laird JR, Jurkovitz CT, Lansky AJ, Gerrits F, Kosinski AS, Murrah N, Weintraub WS; Peripheral Artery Radiation Investigational Study (PARIS) Investigators.

J Vasc Interv Radiol. 2001 Aug;12(8):915-21.

PMID:
11487671
26.

Influence of ammonia and pH on protein and amino acid metabolism in LLC-PK1 cells.

Jurkovitz CT, England BK, Ebb RG, Mitch WE.

Kidney Int. 1992 Sep;42(3):595-601.

Supplemental Content

Loading ...
Support Center